The Claim
Supplementation with nicotinamide mononucleotide (NMN) partially restores NAD+ levels and rescues endothelial angiogenic functions impaired by CHKA silencing in vitro and in vivo, indicating that CHKA regulates angiogenesis through NAD+ metabolism.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Nicotinamide mononucleotide supplementation restores NAD+ levels and reverses impaired blood vessel formation caused by reduced CHKA activity in laboratory cell cultures and animal models.
See the scientific wording
Supplementation with nicotinamide mononucleotide (NMN) partially restores NAD+ levels and rescues endothelial angiogenic functions impaired by CHKA silencing in vitro and in vivo, indicating that CHKA regulates angiogenesis through NAD+ metabolism.
When CHKA is active, it keeps NAD+ levels high in blood vessel cells. High NAD+ turns on SIRT1, which removes a chemical tag from a protein called Notch, preventing it from staying active. When Notch is inactive, blood vessel cells can grow new branches and repair damaged vessels. If CHKA is turned off, NAD+ drops, SIRT1 stops working, Notch stays active, and blood vessels lose their ability to grow. Giving NMN restores NAD+, reactivates SIRT1, turns off Notch, and brings back blood vessel growth.
What the research says
1 studyWhen scientists blocked a protein called CHKA, blood vessels couldn't grow properly—but giving a supplement called NMN fixed half of that problem. This shows CHKA helps blood vessels grow by controlling NAD+ levels.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.